Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22277784 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
Condition: Non-small Cell Lung Cancer Metastatic
Intervention:

Indicates status has not been verified in more than two years